Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure

Europace

Volumn 3, Issue 1, 2001, Pages 29-38

  Notarius, C F ^a,b   Floras, J S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Heart failure; Heart rate variability; Spectral analysis; Sympathetic nervous system

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ATROPINE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NEUROTRANSMITTER; NORADRENALIN; OXYGEN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTONOMIC NERVOUS SYSTEM; CAT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DOG; HEART FAILURE; HEART FUNCTION; HEART INNERVATION; HEART RATE VARIABILITY; HEART TRANSPLANTATION; HUMAN; KINESIOTHERAPY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY; SYMPATHETIC INNERVATION; SYMPATHETIC TONE;

EID: 0035117161     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2000.0136     Document Type: Review

References (97)

1. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog
2. Assessment of autonomic function in humans by heart rate spectral analysis
3. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control
4. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
5. Repeatability of spectral components of short-term blood pressure and heart rate variability during sympathetic activation in healthy male subjects
6. Coarse-graining spectral analysis: New method for studying heart rate variability
7. Heart rate variability and fractal dimension during orthostatic challenges
8. Fractal component of variability of heart rate and systolic blood pressure in congestive heart failure
9. Continuous positive airway pressure increases heart rate variability in congestive heart failure
10. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure
11. Fractal electrodynamics of the heartbeat
12. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure
13. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation
14. Is heart rate variability a reliable method to assess autonomic modulation in left ventricular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability
15. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
16. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart)
17. Prognostic value of heart rate variability in chronic heart failure secondary to idiopathic or ischemic dilated cardiomyopathy
18. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
19. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure
20. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure
21. Normalization of total body and regional sympathetic hyperactivity in heart failure after transplantation
22. After-effects of exercise on hemodynamics and sympathetic nerve activity in young subjects with dilated cardiomyopathy
23. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure
24. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity
25. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct microneurographic recordings
26. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure
27. How to assess sympathetic activity in humans
28. Current clinical applications of heart rate variability
29. Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs
30. Spectral analysis of sympathetic discharge, R-R interval and systolic arterial pressure in decerebrate cats
31. Autonomic control of heart rate during physical exercise and fractal dimension of heart rate variability
32. Comparison of sympathetic nerve activity and heart rate variability responses to lower body negative pressure
33. LF/HF ratio as an index of sympathetic nerve activity in humans
34. Sympathovagal balance: A critical appraisal
35. Low-frequency components of cardiovascular variabilities as markers of sympathetic modulation
36. Heart rate variability: Disagreement on the markers of sympathetic and parasympathetic activities
37. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans
38. Heart rate variability at rest and exercise: Influence of age, gender, and physical training
39. Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans
40. Cardiovascular neural regulation explored in the frequency domain
41. Components of heart rate variability - What they really mean and what we really measure
42. Pitfalls in the interpretation of spectral analysis of the heart rate variability during exercise in humans
43. Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure
44. Effect of autonomic blockade on power spectrum of heart rate variability during exercise
45. Reductions in filling pressure lower cardiac norepinephrine spillover in patients with chronic heart failure
46. Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans
47. Adverse consequences of high sympathetic nerve activity in the failing human heart
48. Pulmonary and peripheral vascular factors are important determinants of peak oxygen uptake in patients with heart failure
49. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects
50. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A sub-study of the studies of left ventricular dysfunction (SOLVD)
51. Endogenous catecholamine levels in chronic heart failure
52. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure
53. Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease
54. Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity
55. Comparison of heart rate spectral analysis with cardiac noradrenaline spillover and muscle sympathetic nerve activity in human subjects
56. Cardiac sympathetic nerve function in congestive heart failure
57. 1-selective and nonselective b-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure
58. 2-adrenoreceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart
59. Modulation of in situ canine intrinsic cardiac neuronal activity by nicotinic, muscarinic, and b-adrenergic agonists
60. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy
61. Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure
62. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants
63. Frequency domain measures of heart period variability and mortality after myocardial infarction
64. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction
65. Heart rate variability and cardiac failure
66. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: Demonstration in human subjects and verification in a paced canine model of ventricular failure
67. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure
68. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure
69. Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors
70. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure
71. Heart rate variability and autonomic balance in patients with different stages of severe congestive heart failure
72. Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease
73. Autonomic pathophysiology in heart failure patients. Sympathetic-Cholinergic Interrelations
74. Functional significance of presynaptic a-adrenergic receptors in the failing and non-failing human left ventricle
75. Ganglionic mechanisms contribute to diminished vagal control in heart failure
76. Parasympathetic control of cardiac sympathetic activity. Normal ventricular function versus congestive heart failure
77. Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle
78. Contribution to heart rate variability by mechanoelectric feedback-Stretch of the sinoatrial node reduces heart rate variability
79. Impact of changes in respiratory frequency and posture on power spectral analysis of heart rate and systolic blood pressure variability in normal subjects and patients with heart failure
80. Important influence of respiration on human R-R interval power spectra is largely ignored
81. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis
82. Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic heart failure
83. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability
84. Chemoreceptor dependence of very low frequency rhythms in advanced heart failure
85. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure. Clinical implications and role of augmented peripheral chemosensitivity
86. Effects of enalapril on heart rate variability in patients with congestive heart failure
87. Low-dose but not high-dose captopril increases parasympathetic activity in patients with heart failure
88. Effect of clonidine on heart rate variability in congestive heart failure
89. Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: A longitudinal heart rate variability study
90. Heart rate variability in left ventricular dysfunction and heart failure: Effects and implications of drug treatment
91. Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure
92. Influence of exercise training and restriction of activity on autonomic balance in patients with severe congestive heart failure
93. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function
94. Exercise training in heart failure patients. Does reversing the peripheral abnormalities protect the heart?
95. Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability
96. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration
97. Sympathetic rhythmicity in cardiac transplant recipients